The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia
This randomized controlled trial investigated the effects of finasteride on scalp and serum dihydrotestosterone (DHT) levels in men with androgenetic alopecia. Involving 249 male participants over 42 days, the study demonstrated that finasteride, a 5α-reductase type 2 inhibitor, significantly reduced both scalp and serum DHT in a dose-dependent manner—scalp DHT